After a hysteroscopic myomectomy, how long should medroxyprogesterone acetate (Provera) 20 mg three times daily be continued, what taper schedule is recommended, and what criteria indicate that the myomectomy was adequate versus requiring hysterectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Post-Hysteroscopic Myomectomy Management with Provera

There is no established evidence-based protocol for routine Provera use after hysteroscopic myomectomy, and the dose you're describing (20mg TID = 60mg/day) is not standard for this indication. The FDA-approved dosing for abnormal uterine bleeding is 5-10mg daily for 5-10 days, not 20mg three times daily 1.

Provera Duration and Dosing Post-Myomectomy

Standard Approach

  • If Provera is used post-hysteroscopic myomectomy, the evidence-supported regimen is 20mg daily (not TID) for 2 months 2
  • This single study showed 50% amenorrhea rates and 100% reduction in menstrual flow when medroxyprogesterone 20mg daily was given for 2 months after endometrial resection 2
  • No taper is described in the literature—simply discontinue after the 2-month course 2

Critical Caveat

The 20mg TID dosing you mentioned (60mg/day total) has no supporting evidence for post-myomectomy use. This appears to be off-label and potentially excessive. The acute bleeding protocol uses 20mg TID for only 7 days, then reduces to 20mg daily 3. Prolonged high-dose MPA carries risks including bone density loss and, with extended use beyond 4 years or in women >31 years, increased meningioma risk 4, 5.

Assessing Myomectomy Success

Timeline for Evaluation

  • Symptom improvement should be evident by 2-3 months post-procedure 6
  • Quality of life scores normalize within this timeframe across all myomectomy approaches 6
  • Reassess at 3-6 month intervals to determine if symptoms are controlled 1

Success Criteria

The myomectomy was adequate if:

  • Heavy menstrual bleeding is controlled (88.5% success rate expected) 7
  • Bulk symptoms (pressure, bladder/bowel symptoms) resolve
  • Anemia improves with normalized hemoglobin
  • Patient reports acceptable quality of life

Consider myomectomy failure if:

  • Persistent heavy menstrual bleeding despite 3-6 months post-op
  • Recurrent or worsening bulk symptoms
  • Ongoing anemia requiring transfusion
  • Unacceptable quality of life impact

When to Consider Hysterectomy

Primary Indications

Move toward hysterectomy when:

  1. Failed myomectomy with persistent symptoms beyond 6 months
  2. Reintervention required—22% of hysteroscopic myomectomies cannot be completed in one session; 10% require reoperation 7
  3. Concurrent adenomyosis—these patients are "less likely to experience symptom relief from hysteroscopic myomectomy" and may need definitive surgery 6
  4. Significant intramural or subserosal fibroid burden causing symptoms—hysteroscopic approach only addresses submucosal fibroids 6
  5. Patient has completed childbearing and desires definitive treatment

Important Considerations

  • Hysterectomy provides definitive resolution of all fibroid-related symptoms 6
  • Even with ovarian preservation, hysterectomy carries increased cardiovascular and mood disorder risks, especially when performed at younger ages 6
  • The 2024 ACR guidelines emphasize hysterectomy should be reserved for patients with no desire for future fertility 6

Practical Algorithm

At 2-3 months post-op:

  • Assess bleeding pattern, bulk symptoms, hemoglobin
  • If improved → continue observation, recheck at 6 months
  • If unchanged/worse → imaging to assess residual/recurrent fibroids

At 6 months post-op:

  • If symptoms controlled → annual follow-up
  • If symptoms persist → counsel regarding hysterectomy vs. alternative treatments (UAE, MRgFUS)
  • If concurrent adenomyosis identified → strongly consider hysterectomy as definitive option

Bottom line: The evidence does not support your proposed 20mg TID Provera regimen. If using MPA post-myomectomy, use 20mg daily for 2 months maximum, then stop without taper. Assess success at 3-6 months based on bleeding control and symptom resolution. Consider hysterectomy for failed myomectomy, concurrent adenomyosis, or when fertility is not desired and symptoms persist.

Related Questions

Is the weight gain associated with Depo‑Provera (medroxyprogesterone acetate) still due to excess caloric intake?
Can a 28-year-old woman who has been using depot medroxyprogesterone acetate (Depo‑Provera) for three years switch to a combined oral contraceptive pill?
Should a 22-year-old woman with recent 13% weight loss, post‑prandial nausea, irregular periods, a new sexual partner, and recent initiation of the contraceptive injection (depot medroxyprogesterone acetate) undergo an urgent transvaginal ultrasound and be screened with a cervical smear?
Should an 18-year-old who has been receiving the Depo-Provera (medroxyprogesterone acetate) injection for three years undergo a bone-density test?
What checklist should be used before initiating Depo‑Provera (medroxyprogesterone acetate) contraception, including pregnancy testing, contraindications, baseline assessments, counseling points, and follow‑up requirements?
At what age is cardiopulmonary clearance required before major surgery or high‑risk procedures?
What parameters are affected by a decrease in peak inspiratory pressure (PIP)?
What Doppler ultrasound findings in the descending thoracic aorta indicate hemodynamically significant coarctation?
How often should a 1-year-old child receive Polytrim (polymyxin B/trimethoprim) eye drops for bacterial conjunctivitis (pink eye)?
When is Augmentin (amoxicillin‑clavulanate) indicated for treating Salmonella infection?
What are the proper precautions for collecting and handling a serum ammonia sample?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.